How AI is quietly changing everyday life
By Olivia Olander, Mackenzie Wilkes, Katy O’Donnell, Daniel Payne, and Ruth Reader,
Politico
| 02. 04. 2024
Photo by National Cancer Institute on Unsplash
Artificial intelligence isn’t just a niche tool for cheating on homework or generating bizarre and deceptive images. It’s already humming along in unseen and unregulated ways that are touching millions of Americans who may never have heard of ChatGPT, Bard or other buzzwords.
A growing share of businesses, schools, and medical professionals have quietly embraced generative AI, and there’s really no going back. It is being used to screen job candidates, tutor kids, buy a home and dole out medical advice.
The Biden administration is trying to marshal federal agencies to assess what kind of rules make sense for the technology. But lawmakers in Washington, state capitals and city halls have been slow to figure out how to protect people’s privacy and guard against echoing the human biases baked into much of the data AIs are trained on.
“There are things that we can use AI for that will really benefit people, but there are lots of ways that AI can harm people and perpetuate inequalities and discrimination that we’ve seen for our...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...